Epithelial-mesenchymal transition in tissue repair and fibrosis
- PMID: 27461257
- PMCID: PMC5011038
- DOI: 10.1007/s00441-016-2464-0
Epithelial-mesenchymal transition in tissue repair and fibrosis
Abstract
The epithelial-mesenchymal transition (EMT) describes the global process by which stationary epithelial cells undergo phenotypic changes, including the loss of cell-cell adhesion and apical-basal polarity, and acquire mesenchymal characteristics that confer migratory capacity. EMT and its converse, MET (mesenchymal-epithelial transition), are integral stages of many physiologic processes and, as such, are tightly coordinated by a host of molecular regulators. Converging lines of evidence have identified EMT as a component of cutaneous wound healing, during which otherwise stationary keratinocytes (the resident skin epithelial cells) migrate across the wound bed to restore the epidermal barrier. Moreover, EMT plays a role in the development of scarring and fibrosis, as the matrix-producing myofibroblasts arise from cells of the epithelial lineage in response to injury but are pathologically sustained instead of undergoing MET or apoptosis. In this review, we summarize the role of EMT in physiologic repair and pathologic fibrosis of tissues and organs. We conclude that further investigation into the contribution of EMT to the faulty repair of fibrotic wounds might identify components of EMT signaling as common therapeutic targets for impaired healing in many tissues. Graphical Abstract Model for injury-triggered EMT activation in physiologic wound repair (left) and fibrotic wound healing (right).
Keywords: Dermal fibroblasts; Epithelial-mesenchymal transition; Fibrosis; Keratinocytes; Wound healing.
Figures
Similar articles
-
Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-alpha through bone morphogenic protein-2.Am J Pathol. 2010 May;176(5):2247-58. doi: 10.2353/ajpath.2010.090048. Epub 2010 Mar 19. Am J Pathol. 2010. PMID: 20304956 Free PMC article.
-
GRHL2 regulates keratinocyte EMT-MET dynamics and scar formation during cutaneous wound healing.Cell Death Dis. 2024 Oct 14;15(10):748. doi: 10.1038/s41419-024-07121-7. Cell Death Dis. 2024. PMID: 39402063 Free PMC article.
-
Electric field-induced suppression of PTEN drives epithelial-to-mesenchymal transition via mTORC1 activation.J Dermatol Sci. 2017 Feb;85(2):96-105. doi: 10.1016/j.jdermsci.2016.11.007. Epub 2016 Nov 18. J Dermatol Sci. 2017. PMID: 27919618
-
Type 2 epithelial mesenchymal transition in vivo: truth or pitfalls?Chin Med J (Engl). 2012 Sep;125(18):3312-7. Chin Med J (Engl). 2012. PMID: 22964329 Review.
-
Involvement of epithelial-mesenchymal transition in liver fibrosis.Saudi J Gastroenterol. 2018 Jan-Feb;24(1):5-11. doi: 10.4103/sjg.SJG_297_17. Saudi J Gastroenterol. 2018. PMID: 29451178 Free PMC article. Review.
Cited by
-
Genome-wide identification of methylated CpG sites in nongenital cutaneous warts.BMC Med Genomics. 2020 Jul 8;13(1):100. doi: 10.1186/s12920-020-00745-6. BMC Med Genomics. 2020. PMID: 32641122 Free PMC article.
-
Amyloid precursor protein as a fibrosis marker in infants with biliary atresia.Pediatr Res. 2024 Sep 28. doi: 10.1038/s41390-024-03582-w. Online ahead of print. Pediatr Res. 2024. PMID: 39341941
-
Thalidomide Attenuates Skin Lesions and Inflammation in Rosacea-Like Mice Induced by Long-Term Exposure of LL-37.Drug Des Devel Ther. 2022 Dec 2;16:4127-4138. doi: 10.2147/DDDT.S393122. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36483458 Free PMC article.
-
Tannic acid prevents macrophage-induced pro-fibrotic response in lung epithelial cells via suppressing TLR4-mediated macrophage polarization.Inflamm Res. 2019 Dec;68(12):1011-1024. doi: 10.1007/s00011-019-01282-4. Epub 2019 Sep 5. Inflamm Res. 2019. PMID: 31489459
-
PLODs: Novel prognostic biomarkers and potential immunotherapy targets for head and neck squamous cell carcinoma.Heliyon. 2023 Feb 3;9(2):e13479. doi: 10.1016/j.heliyon.2023.e13479. eCollection 2023 Feb. Heliyon. 2023. PMID: 36820030 Free PMC article.
References
-
- Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. Journal of immunology (Baltimore, Md : 1950) 2001;166:7556–7562. - PubMed
-
- Aden N, Nuttall A, Shiwen X, de Winter P, Leask A, Black CM, Denton CP, Abraham DJ, Stratton RJ. Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis. The Journal of investigative dermatology. 2010;130:2191–2200. - PubMed
-
- Ahmed N, Maines-Bandiera S, Quinn MA, Unger WG, Dedhar S, Auersperg N. Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. American journal of physiology Cell physiology. 2006;290:C1532–C1542. - PubMed
-
- Akhurst RJ, Derynck R. TGF-beta signaling in cancer--a double-edged sword. Trends in cell biology. 2001;11:S44–S51. - PubMed
-
- Arnoux V, Come C, Kusewitt D, Hudson L, Savagner P. Cutaneous wound reepithelialization: a partial and reversible EMT. In: Savagner P, editor. Rise and fall of epithelial phenotype: concepts of epithelial-mesenchymal transition. Berlin: Springer; 2005. pp. 111–134.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous